Stock Yards Bank & Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.04M | Sell |
14,633
-2
| -0% | -$280 | 0.06% | 161 |
|
|
2025
Q4 | $1.8M | Sell |
14,635
-10,135
| -41% | -$1.23M | 0.06% | 169 |
|
|
2025
Q3 | $2.75M | Sell |
24,770
-450
| -2% | -$51.1K | 0.09% | 129 |
|
|
2025
Q2 | $2.8M | Buy |
25,220
+23,064
| +1,070% | +$2.45M | 0.09% | 123 |
|
|
2025
Q1 | $242K | Buy |
+2,156
| New | +$222K | 0.01% | 351 |
|
|
2024
Q3 | – | Sell |
-3,162
| Closed | -$217K | – | 380 |
|
|
2024
Q2 | $217K | Sell |
3,162
-251
| -7% | -$16.8K | 0.01% | 361 |
|
|
2024
Q1 | $250K | Buy |
3,413
+253
| +8% | +$19.5K | 0.01% | 362 |
|
|
2023
Q4 | $256K | Sell |
3,160
-75
| -2% | -$5.84K | 0.01% | 345 |
|
|
2023
Q3 | $242K | Sell |
3,235
-613
| -16% | -$47.1K | 0.01% | 343 |
|
|
2023
Q2 | $297K | Sell |
3,848
-808
| -17% | -$64.4K | 0.01% | 337 |
|
|
2023
Q1 | $387K | Sell |
4,656
-132
| -3% | -$10.9K | 0.01% | 310 |
|
|
2022
Q4 | $411K | Buy |
4,788
+272
| +6% | +$21.5K | 0.02% | 318 |
|
|
2022
Q3 | $279K | Sell |
4,516
-150
| -3% | -$9.46K | 0.01% | 349 |
|
|
2022
Q2 | $289K | Buy |
+4,666
| New | +$289K | 0.01% | 354 |
|
|
2017
Q3 | – | Sell |
-14,145
| Closed | -$1M | – | 216 |
|
|
2017
Q2 | $1M | Sell |
14,145
-4,227
| -23% | -$281K | 0.12% | 102 |
|
|
2017
Q1 | $1.25M | Sell |
18,372
-87,368
| -83% | -$6.14M | 0.16% | 95 |
|
|
2016
Q4 | $7.57M | Sell |
105,740
-7,614
| -7% | -$566K | 0.99% | 42 |
|
|
2016
Q3 | $8.97M | Buy |
113,354
+1,617
| +1% | +$131K | 1.22% | 33 |
|
|
2016
Q2 | $9.32M | Buy |
111,737
+13,527
| +14% | +$1.2M | 1.24% | 30 |
|
|
2016
Q1 | $9.02M | Buy |
98,210
+2,252
| +2% | +$203K | 1.29% | 29 |
|
|
2015
Q4 | $9.71M | Buy |
95,958
+1,099
| +1% | +$114K | 1.35% | 27 |
|
|
2015
Q3 | $9.31M | Sell |
94,859
-2,268
| -2% | -$252K | 1.42% | 24 |
|
|
2015
Q2 | $11.4M | Buy |
97,127
+1,311
| +1% | +$143K | 1.62% | 18 |
|
|
2015
Q1 | $9.4M | Buy |
95,816
+6,344
| +7% | +$644K | 1.33% | 30 |
|
|
2014
Q4 | $8.43M | Buy |
89,472
+2,769
| +3% | +$286K | 1.2% | 32 |
|
|
2014
Q3 | $9.23M | Buy |
86,703
+2,661
| +3% | +$261K | 1.4% | 26 |
|
|
2014
Q2 | $6.97M | Buy |
84,042
+80,547
| +2,305% | +$6.27M | 0.99% | 38 |
|
|
2014
Q1 | $248K | Buy |
3,495
+250
| +8% | +$19.6K | 0.04% | 200 |
|
|
2013
Q4 | $244K | Hold |
3,245
| – | – | 0.04% | 192 |
|
|
2013
Q3 | $204K | Buy |
+3,245
| New | +$194K | 0.03% | 197 |
|
Other funds holding GILD
VCM
VPM
Stock Yards Bank & Trust's GILD Position: Q1 2026 in Review
Stock Yards Bank & Trust reduced its Gilead Sciences (GILD) stake by 0.01% in Q1 2026, selling an estimated $280 and leaving 14,633 shares worth $2.04M. The position accounts for 0.06% of the portfolio, ranked #161.
Stock Yards Bank & Trust first reported a position in GILD in Q3 2013 and has held it in 30 quarters since. The position peaked at $11.4M in Q2 2015. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Stock Yards Bank & Trust held 14,633 shares of Gilead Sciences worth $2.04M as of Q1 2026.
- Stock Yards Bank & Trust sold 2 Gilead Sciences shares in Q1 2026, an estimated $280.
- Gilead Sciences made up 0.06% of Stock Yards Bank & Trust's portfolio in Q1 2026, its #161 holding.
- Stock Yards Bank & Trust first reported a position in Gilead Sciences in Q3 2013 and has held it in 30 quarters since.
- Stock Yards Bank & Trust's Gilead Sciences position peaked at $11.4M in Q2 2015.
- 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Stock Yards Bank & Trust's 13F filing for Q1 2026, filed 24 Apr 2026.